- The Washington Times - Thursday, January 31, 2002

Enron and Arthur Andersen have nothing over the National Academy of Sciences when it comes to deceiving the public.

An NAS panel opined recently that human reproductive cloning should be banned, but that cloning for medical research purposes euphemistically termed "creation of embryonic stems cells by nuclear transplantation" should be allowed.

The NAS' recommendations were trumpeted by major media such as The Washington Post and the New York Times in front-page stories coupled with sycophantic editorials.

But these illustrious media outlets, so eager to report Enron's shady doings, gave the NAS' skullduggery a free pass. They failed to report information exposing the NAS' recommendations as the best pre-determined conclusions taxpayer money can buy.

Taxpayer-funded medical research is big business. Billions of dollars pour into the National Institutes of Health every year. Entrepreneurial researchers often turn the fruits of this taxpayer-funded research into lucrative private businesses.

Last August, President Bush threatened growth prospects for an emerging sector of this business.

Weighing the morality of human embryo destruction against the potential of medical research, the president limited the flow of taxpayer dollars to embryonic stem cell research hyped as possibly leading to cures for many diseases such as cancer, diabetes, Parkinson's and Alzheimer's.

The president's action disappointed stem cell researchers who so far have relied on monies raised in the capital markets. This funding is insufficient and may eventually disappear as investors realize that financial returns from stem cell research might be decades away if at all.

Enter Bruce Alberts, the Wizard of Oz-like president of the NAS.

The politically savvy Mr. Alberts fancies taxpayer spigots can be opened by pressuring President Bush. What better way than through widely-publicized recommendations from the NAS, an elite organization whose elected members represent the cream of U.S. scientists?

On his own initiative, Mr. Alberts put together a special panel, stacked with embryonic stem cell research proponents and researchers already on the taxpayer dole.

Mr. Alberts deserves an "Ig Nobel" Prize for picking Stanford University's Irving Weissman as panel chairman.

Mr. Weissman has received 131 research grants courtesy of taxpayers, including 22 for stem cell research. The grants pale in comparison to the real fruits of his research.

Mr. Weissman co-founded Systemix, Inc., a 1990s stem cell research company. Systemix sold for $468 million, netting Weissman a cool $20 million even though the company failed to deliver on expected cancer and AIDS therapies. Mr. Weissman then co-founded StemCells Inc., currently with a market value of about $80 million.

Mr. Weissman isn't the only panel member predisposed to taxpayer-funded research and its exploitation.

The 11 members of the NAS panel have garnered 596 grants from taxpayers. Three other panel members are officers in professional societies affiliated with the Federation of American Societies for Experimental Biology a group lobbying for federal funding of embryonic stem cell research.

Breastfeeding off taxpayers is as natural to the NAS panel members as breathing.

But there's more.

Panel member David Galas (eight grants) has interests in two biotech companies, Chiroscience R&D Inc. and Blue Heron Biotechnology Co. Panel member Gerald Rubin (71 grants) co-founded Exelixis, Inc., a genomic research company worth $694 million. Even the NAS member overseeing the panel's work, Maxine Singer, is a director of Perlegen Sciences Inc., a genomics company that just raised $100 million.

Was there any chance this panel would recommend against federal funding of embryonic stem cell research? Not if Wizard Alberts could help it.

Were these conflicts fully and frankly disclosed by the NAS? No.

There are passing mentions on the NAS Web site of Mr. Weissman's links with Systemix and StemCells and Mr. Galas' link with Chiroscience. But panel members' grant histories, other corporate links and financial info, and FASEB connections were omitted. And, of course, no mention of these conflicts appeared in media coverage.

Last summer when the panel was formed, the National Journal asked about omitted disclosures from the NAS Web site. NAS executive officer E. William Colglazier offered an Enron-ish explanation, "It is up to our discretion to decide what we put in the bios."

Mr. Alberts stated at a press conference that the NAS undertook the report "because we believe the nation needs a clear, unbiased scientific examination of proposals for human reproductive cloning." He then introduced Mr. Weissman merely as a "professor of cancer biology, pathology and developmental biology at Stanford University School of Medicine."

I guess "taxpayer-made, stem-cell tycoon" would have made the audience howl with laughter.

Steven Milloy is the publisher of JunkScience.com, an adjunct scholar at the Cato Institute and the author of "Junk Science Judo: Self-defense Against Health Scares and Scams" (Cato Institute, 2001).

Copyright © 2019 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide